SCHEMBL5828850

SCHEMBL5828850

COc1cc2c(N/C(=N\c3c(C)cccc3C)NCCCN(C)C)ncnc2cc1OCc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 2/20 0.49
EHMT2 Q96KQ7 2/20 0.49
RCOR1 Q9UKL0 2/20 0.49
EGFR P00533 9/20 0.49
MAPK1 P28482 2/20 0.46
KDR P35968 2/20 0.45
HTT P42858 3/20 0.45
HPGD P15428 2/20 0.45
EZH2 Q15910 1/20 0.45
PRMT1 Q99873 1/20 0.45
KMT5A Q9NQR1 1/20 0.45
KDM4E B2RXH2 1/20 0.45
LMNA P02545 1/20 0.45
LCK P06239 1/20 0.44
RET P07949 2/20 0.44
KIF5B P33176 1/20 0.44
AURKB Q96GD4 1/20 0.43
IRAK4 Q9NWZ3 1/20 0.43
ALDH1A1 P00352 1/20 0.43
RAF1 P04049 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5828851 1.00 KDM1A (0.49) KDM1AEHMT2RCOR1EGFRMAPK1
SCHEMBL5828729 0.95 EGFR (0.50) KDM1AEHMT2RCOR1EGFRMAPK1
SCHEMBL5828728 0.95 EGFR (0.50) KDM1AEHMT2RCOR1EGFRMAPK1
SCHEMBL5827881 0.93 RET (0.47) EGFRMAPK1KDRHTTHPGD
SCHEMBL5827885 0.93 RET (0.47) EGFRMAPK1KDRHTTHPGD
SCHEMBL5828872 0.88 HTT (0.48) EGFRMAPK1KDRHTTHPGD
SCHEMBL5828868 0.88 HTT (0.48) EGFRMAPK1KDRHTTHPGD
SCHEMBL6986020 0.88 EGFR (0.46) EGFRKDRHTTHPGDRET
SCHEMBL6985326 0.83 EGFR (0.49) KDM1AEHMT2RCOR1EGFRMAPK1
SCHEMBL6981093 0.82 EGFR (0.47) EGFRKDRHTTHPGDRET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7001904-B1 Guanidine derivatives quinazoline and quinoline for use in the treatment of autoimmune diseases ASTRAZENECA AB (SE) 2006-02-21 US disclosed
EP-1296973-A1 GUANIDINE DERIVATIVES OF QUINAZOLINE AND QUINOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES AstraZeneca AB (SE) 2003-04-02 EP disclosed
WO-2002000644-A1 GUANIDINE DERIVATIVES OF QUINAZOLINE AND QUINOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES ASTRAZENECA AB (SE) 2002-01-03 WO disclosed